Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $21.6 million for 2020, marking a 4.3% increase from 2019. Net sales rose by 10.4% to $175.1 million, driven by growth in Human and Animal Nutrition sectors. Adjusted net earnings reached $26.9 million, up 2.3% year-over-year, with adjusted EBITDA at $44.4 million, a 10.1% increase. Cash flows from operations were $35.4 million and free cash flow was $28.3 million. The company's net debt decreased to $114.6 million. Balchem continues to implement its ERP system and advances its ESG commitments.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for October 28, 2020, at 11:00 AM ET to discuss its third-quarter results, which will be published before market opening on the same day. The call will be hosted by CEO Ted Harris and CFO Martin Bengtsson, with a replay available until November 11, 2020. The company, known for enhancing health through its specialty ingredients across various sectors, operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at Morningstar's Management Behind the Moat Conference on September 29, 2020, at 9:00 a.m. EDT. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Interested parties can access the presentation materials prior to the event at here.
Balchem focuses on specialty ingredients within three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at the Sidoti Fall 2020 Virtual Investor Conference on September 23, 2020, starting at 2:30 p.m. EDT. The presentation will be led by CEO Ted Harris and CFO Martin Bengtsson. Investors can access a live webcast of the event through a specified link, with a replay available approximately 24 hours later until December 23, 2020.
Balchem specializes in developing and marketing ingredients for health and well-being across various industries, with segments in Human Nutrition, Animal Nutrition, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported a record net earnings of $21.1 million for Q2 2020, reflecting an increase from $19.8 million in Q2 2019. Adjusted net earnings rose to $27.6 million, up 9.2% year-over-year. Net sales reached $173.4 million, a 7.3% increase compared to the previous year. The company's adjusted EBITDA also hit a record $43.9 million, marking a 9.8% growth. Strong cash flow allowed for $35.0 million in debt repayment, reducing net debt to $142.2 million.
Summary not available.
Summary not available.